Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Filings indexed 1,018 across all filing types
Latest filing 2026-03-09 Regulatory Filings
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Consolidated accounts of parent company for subsidiary company period ending 30/06/25
Regulatory Filings
2026-03-09 English
[accounts-with-accounts-type-audit-exemption-subsiduary] made_up_date=2025-06-30
Regulatory Filings
2026-03-09 English
Full accounts made up to 2024-06-30
Regulatory Filings
2025-03-03 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number' and contains the header 'This information is provided by RNS, the news service of the London Stock Exchange.' RNS stands for Regulatory News Service, which is a general regulatory announcement mechanism in the UK. The content details a 'TR-1: Standard form for notification of major holdings' by JPMorgan Chase & Co., indicating a change in significant share ownership (crossing a threshold). While 'Major Shareholding Notification' (MRQ) is a specific category, the presence of the RNS branding and the nature of the filing (a standard regulatory disclosure form) strongly suggests the general regulatory announcement category is the most appropriate fit, especially given the RNS context provided in the document itself. Since this is a standard regulatory disclosure published via RNS, and it fits the description of a regulatory announcement, RNS is the best fit, although MRQ is also highly relevant. Given the explicit RNS context, I will classify it as RNS.
2024-01-23 English
Holding(s) in Company
Regulatory Filings Classification · 98% confidence The document is explicitly labeled with "RNS Number : 1989A" and contains the standard footer information indicating it is provided by RNS, the news service of the London Stock Exchange. The content is a "TR-1: Standard form for notification of major holdings," detailing a change in voting rights held by Barclays PLC. This type of mandatory disclosure regarding significant share ownership changes falls under regulatory reporting. Since there is a specific category for 'Major Shareholding Notification' (MRQ), that is the most precise fit. If MRQ were not available, RNS (General Regulatory Filings) would be the fallback, but MRQ is superior here.
2024-01-18 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with "RNS Number : 1670A" and contains a standard form titled "TR-1: Standard form for notification of major holdings". This form is used to report changes in significant share ownership (crossing thresholds) by major shareholders, which is a regulatory requirement. This specific type of filing, reporting changes in major shareholdings, aligns directly with the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the content is highly specific to share ownership changes, making MRQ the most precise classification over the general RNS fallback.
2024-01-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.